Friday, 03 February 2023
Retention of Products
Products successfully registered or approved by the Medicines Control Authority of Zimbabwe (MCAZ) are published in a drug register. An annual retention fee is required from every holder of a drug registration or approval certificate in line with the statutory fee schedule. Please note that retention fees are paid for the permission to market a registered or an approved product for one year and they are due and payable by 1st April each year.
Drug Registers
A list of the MCAZ drug registers is provided below with all approved or registered medicines.
The draft Blood and Blood Components Regulations are now available Please note that this is a DRAFT that has been uploaded to obtain comments from stakeholders before the regulations are...
This Medical Product Alert warns consumers, healthcare professionals, and health authorities against a growing number of falsified medical products that claim to prevent, detect, treat orcure COVID-19. Medical...
Draft SADC Variations Guidelines are now available Click the following links to download the guidelines and the comments sheet Draft SADC Variations Guidelines Draft SADC Variations Guidelines Comments Sheet
In pursuit of promoting high ethical standards, the Authority has formulated a Code of Ethics for its employees and members of the Authority .The Authority believes that high ethical...
Southern African Development Community (SADC), as a region has harmonized medicines registration guidelines in the common technical document (CTD) format that were approved in January 2015. Nevertheless, the harmonization...
JOB ADVERTISEMENT: DIRECTOR-GENERAL, GRADE F2 The Medicines Control Authority of Zimbabwe (MCAZ) is inviting applications from suitably qualified, honest, self-motivated and experienced applicants for the following vacant position: Director-General X...